KeyBanc's John Vinh on Qualcomm Q1 results, China's DeepSeek AI development
John Vinh, KeyBanc Capital Markets equity research analyst, joins 'Squawk Box' to break down Qualcomm's quarterly earnings ...
Bio-Techne price target raised to $90 from $80 at KeyBanc
KeyBanc raised the firm’s price target on Bio-Techne (TECH) to $90 from $80 and keeps an Overweight rating on the shares. Overall, fiscal Q2 ...
KeyBanc Keeps Their Buy Rating on Hillenbrand (HI)
KeyBanc analyst Jeffrey Hammond reiterated a Buy rating on Hillenbrand (HI – Research Report) today. The company’s shares closed yesterday at ...
Robinhood Markets, Inc. (HOOD): Among Cathie Wood’s Top Stock Picks for 2025
Robinhood Markets, Inc. (NASDAQ:HOOD) had another excellent quarter in fiscal Q3 2024, recording its second-highest revenues ...
KeyBanc raises PTC Inc. stock target to $211, retains overweight
KeyBanc Capital Markets increased its price target for PTC Inc. (NASDAQ:PTC) shares from $205.00 to $211.00, while maintaining an Overweight rating. The adjustment follows PTC's first-quarter constant ...